Immediate Impact
1 from Science/Nature 44 standout
Citing Papers
Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision
2024 Standout
Chemistry, structure and function of approved oligonucleotide therapeutics
2023 Standout
Works of F. Benoudiba being referenced
Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation)
2018
Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| F. Benoudiba | 97 | 226 | 55 | 151 | 107 | 38 | 466 | |
| Adnan Dağçınar | 157 | 153 | 49 | 122 | 131 | 57 | 488 | |
| Sangjoon Chong | 124 | 175 | 30 | 101 | 120 | 40 | 544 | |
| Nicola Benedetto | 144 | 188 | 74 | 131 | 136 | 31 | 508 | |
| Alper Baysefer | 121 | 258 | 70 | 106 | 89 | 37 | 500 | |
| Enrico Giordan | 212 | 175 | 42 | 80 | 125 | 48 | 494 | |
| Ekkehard Kasper | 197 | 165 | 48 | 71 | 137 | 31 | 555 | |
| D Maîtrot | 108 | 272 | 124 | 72 | 72 | 41 | 548 | |
| Uwe Max Mauer | 94 | 145 | 55 | 111 | 110 | 33 | 414 | |
| Nurullah Yüceer | 88 | 207 | 74 | 48 | 70 | 53 | 470 | |
| Fareed Jumah | 191 | 152 | 77 | 60 | 60 | 57 | 565 |
All Works
Loading papers...